Alkuri Global Acquisition Corp.
KURI
NASDAQ Global Select9.20
USD
-0.40
- -
CIK
0001836967
ISIN
US66981N2027
Return %
Stock
S&P500
1Y
- -
26.57
3Y
-5.73
76.60
5Y
-5.73
78.48
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- CEO
- Richard Williams
- Sector
- Financial Services
- Industry
- Shell Companies
- Address
- 4235 Hillsboro Pike Nashville TN United States of America
- IPO Date
- Mar 30, 2021
- CIK
- 0001836967
- Website
- alkuri.com
- Similar Companies
- Business
- Alkuri Global Acquisition Corp. operates as a special purpose acquisition company (SPAC) focused on effecting mergers, capital stock exchanges, asset acquisitions, stock purchases, reorganizations, or similar business combinations primarily within the technology sector, with a particular focus on companies leveraging data and artificial intelligence in Consumer Internet, Marketplaces, Healthtech, Fintech, and Mobility segments. Founded in 2020 and headquartered in Delaware, the company itself does not manufacture or sell products but serves as a vehicle for acquiring or merging with one or more businesses that fit its strategic criteria. A major recent development for Alkuri Global Acquisition Corp. is its successful business combination with Babylon Holdings Ltd., a rapidly growing digital healthcare company specializing in AI-powered telehealth services including video medical consultations and AI diagnostics. This merger was completed in October 2021, after which Babylon Holdings began trading publicly under the ticker symbols BBLN and BBLN.W on the New York Stock Exchange, marking Alkuri's transition from a blank check company to being part of a publicly traded digital health enterprise. This marks Alkuri's key strategic shift from a SPAC to an operating public company through the acquisition of Babylon Holdings. The company's core products and services are now centered on Babylon's offerings, which include digital healthcare platforms that integrate AI for virtual consultations, health monitoring, and diagnostics, primarily targeting patients through partnerships with healthcare providers and payors around the globe, including significant operations in the United Kingdom and expansion initiatives in other regions. Alkuri's strategic focus continues to target innovative technology-driven healthcare and related markets post-merger. The executive leadership team brought on through the transaction includes professionals with substantial experience in technology, healthcare, and digital consumer services, positioning the combined entity for growth in digital health markets.
Peer-reviewed Research Finds Babylon's Digital-first Model Of Primary Care Is Associated With Lower Significantly NHS Hospital Care Costs